CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis

被引：25

作者：

Bojarska-Junak, Agnieszka ^{[1
]}

Hus, Iwona ^{[2
]}

Chocholska, Sylwia ^{[3
]}

Tomczak, Waldemar ^{[3
]}

Wos, Justyna ^{[1
]}

Czubak, Pawel ^{[4
]}

Putowski, Lechoslaw ^{[4
]}

Rolinski, Jacek ^{[1
]}

机构：

[1] Med Univ Lublin, Chair & Dept Clin Immunol, PL-20093 Lublin, Poland

[2] Med Univ Lublin, Dept Clin Transplantol, PL-20093 Lublin, Poland

[3] Med Univ Lublin, Dept Haematooncol & Bone Marrow Transplantat, PL-20093 Lublin, Poland

[4] Med Univ Lublin, Chair & Dept Gynaecol & Gynaecol Endocrinol, PL-20093 Lublin, Poland

来源：

LEUKEMIA RESEARCH | 2014年 / 38卷 / 04期

关键词：

CLL; CD1d; iNKT; CD3; zeta; ZAP; 70; CD38; ZETA-CHAIN EXPRESSION; TUMOR-CELLS; T-CELL; LEF-1; PROGRESSION; IMMUNITY; SUBSETS; ZAP-70; TARGET; GAMMA;

D O I：

10.1016/j.leukres.2013.12.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Through the analysis of CD1d expression by flow cytometry and qRT-PCR we showed lower CD1d molecule and CD1d mRNA expression in B cells of CLL patients than of healthy controls. The frequency of CD1d(+)/CD19(+) cells, CD1d staining intensity and CD1d transcript levels increased with the disease stage. CD1d expression was positively associated with ZAP-70 and CD38 expressions as well as with unfavourable cytogenetic changes. We established the relationship between high CD1d expression and shorter time to treatment and overall survival. We observed that CD1d expression in individual patients significantly changed over time. The percentage of CD1d+/CD19+ cells inversely correlated with the percentage of iNKT cells. (c) 2013 Elsevier Ltd. All rights reserved.

引用

页码：435 / 442

页数：8

共 50 条

[41] CHRONIC LYMPHOCYTIC LEUKEMIA: BIOMARKERS AND PROGNOSIS
Stamatopoulos, Kostas
LEUKEMIA RESEARCH, 2016, 49 : S3 - S4
[42] Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia
Schlosser, Pascal
Schiwitza, Annett
Klaus, Jonas
Hieke-Schulz, Stefanie
Szic, Katarzyna Szarc vel
Duyster, Justus
Trepel, Martin
Zirlik, Katja
Schumacher, Martin
Claus, Rainer
ANNALS OF HEMATOLOGY, 2024, 103 (05) : 1613 - 1622
[43] Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia
Pascal Schlosser
Annett Schiwitza
Jonas Klaus
Stefanie Hieke-Schulz
Katarzyna Szarc vel Szic
Justus Duyster
Martin Trepel
Katja Zirlik
Martin Schumacher
Rainer Claus
Annals of Hematology, 2024, 103 : 1613 - 1622
[44] CHRONIC LYMPHOCYTIC LEUKEMIA: BIOMARKERS AND PROGNOSIS
Stamatopoulos, Kostas
LEUKEMIA RESEARCH, 2017, 61 : S10 - S10
[45] THE PROGNOSIS OF CHRONIC LYMPHOCYTIC-LEUKEMIA
GRECO, MM
MINERVA MEDICA, 1981, 72 (40) : 2709 - 2712
[46] PROGNOSIS FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
PHILLIPS, E
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 274 - 274
[47] Signaling lymphocytic activation molecule family-1 (CD150) expression as a prognostic indicator in patients with chronic lymphocytic leukemia
Elkholy, Rasha A.
Allam, Alzahraa A.
EGYPTIAN JOURNAL OF HAEMATOLOGY, 2018, 43 (03): : 109 - 114
[48] Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia
Zhu, Dan-Xia
Fan, Lei
Lu, Rui-Nan
Fang, Cheng
Shen, Wen-Yi
Zou, Zhi-Jian
Wang, Yin-Hua
Zhu, Hua-Yuan
Miao, Kou-Rong
Liu, Peng
Xu, Wei
Li, Jian-Yong
CANCER SCIENCE, 2012, 103 (05) : 875 - 881
[49] MicroRNA expression profiles associated with prognosis and progression of chronic lymphocytic leukemia
Calin, George Adrian
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 39 - 39
[50] Atypical Chronic Lymphocytic Leukemia with CD200 Expression Shares Similar Outcomes to Classical Chronic Lymphocytic Leukemia
Mongeau-Marceau, Zoe
Cohen, Sandra
Mollica, Luigina
LeBlanc, Richard
Fortin, Bernard
Terra, Rafik
Fleury, Isabelle
BLOOD, 2016, 128 (22)

← 1 2 3 4 5 →